Results of a meta-analysis showed that all biologic agents were superior to placebo for improving short-term outcomes in moderate to severe plaque psoriasis.
Everyday Health on MSN
5 DIY Tricks to Calm Scalp Psoriasis Irritation
For symptoms of scalp psoriasis, home treatments like olive oil, oatmeal, and apple cider vinegar may provide relief and make ...
PSORIASIS is no longer regarded as a single, uniform condition. Once classified primarily by visible lesions or severity, it ...
Psoriasis can feel like an uninvited guest that shows up on your skin and refuses to leave. Those red, scaly patches—often ...
More than 50% of patients with psoriasis are eligible for systemic treatment, and nearly 90% would switch to an effective oral therapy with a favorable safety profile.
The use of interleukin (IL)-23 inhibitors plays an important role in treating patients with psoriasis, as well as in treating ...
Personalized dosing strategies may be necessary for biologic therapies, especially fixed-dose options like ustekinumab, due ...
Copenhagen University Hospital–Herlev and Gentofte led a nationwide registry study that the authors claim shows a "pattern ...
MedPage Today on MSN
More Trial Details Reported for Novel Psoriasis Pill
Subgroup analyses from one of the agent's pivotal trials showed that 29.5% of adolescents receiving icotrokinra achieved PASI ...
Marking World Psoriasis Day on Oct 29, a public welfare initiative was launched in Beijing to raise awareness of fair ...
Horsham: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S.
Every year on 29 October, World Psoriasis Day raises awareness of the 125 million people worldwide living with PsA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results